India Exim Bank conclude US$ 100 million loan agreement with JBIC

The purpose of this facility is to support the Indian healthcare sector related to combating COVID-19

Export-Import Bank of India (India Exim Bank) concluded a USD 100 million loan agreement with Japan Bank for International Cooperation (JBIC), along with three Japanese private financial institutions, namely, MUFG Bank, Ltd., the Bank of Kyoto, Ltd., and the Hachijuni Bank, Ltd., on May 23, 2022, on the side-lines of the Quad Leaders’ Summit.

The purpose of this facility is to support the Indian healthcare sector related to combating COVID-19, including but not limited to vaccine manufacturers, pharmaceutical companies, manufacturers of personal protective equipment, medical oxygen or other medical devices, hospitals, and other related activities.

India Exim Bank and JBIC will jointly work towards expanding safe and effective manufacturing of COVID-19 vaccines and related pharmaceutical and healthcare products in India.

India Exim Bank has been supporting the healthcare sector and all the segments in the pharmaceutical value chain. Apart from supporting domestic expansion projects of the companies in these sectors, the bank has also supported the overseas endeavours of various Indian companies in the healthcare sector (including hospitals and healthcare facilities, pathological labs, and related training/ education services), pharmaceutical companies (including manufacturing of bulk drugs and formulations), and biosimilar/ biopharma (including life sciences) companies, among others. Additionally, India Exim Bank has been supporting research and development, new product development and other related areas.

 

agreementCOVID-19India Exim BankJapan Bank for International Cooperation
Comments (0)
Add Comment